Catatonia: The Board Answer Is a Benzodiazepine, Not an Antipsychotic
Here’s the trap the PMHNP boards build into catatonia: the patient looks floridly psychiatric — mute, posturing, staring — so the tempting move is to reach for an antipsychotic. That’s the wrong answer, and it can be a dangerous one. The board answer for catatonia is a benzodiazepine — lorazepam — and antipsychotics can worsen it and precipitate neuroleptic malignant syndrome. Get that one inversion right and the whole question falls into place.
What catatonia actually is
Catatonia is a psychomotor syndrome — a disturbance of movement, volition, and responsiveness. Think mutism, immobility or purposeless excitement, posturing, waxy flexibility, negativism, echolalia, echopraxia, staring.
The high-yield clinical pearl the exam wants: catatonia most often complicates a mood disorder — classically bipolar disorder and major depression — not just schizophrenia. It also shows up in psychotic illness and, critically, in medical and neurologic disease: autoimmune encephalitis (anti-NMDA receptor), metabolic derangement, infection. The mechanism the boards key on is GABA-A hypoactivity, which is exactly why a GABA agonist both diagnoses and treats it.
It can be a medical emergency
Don’t file catatonia under “interesting psychiatric finding.” At the severe end it’s a medical emergency. An immobile, mute patient stops eating and drinking — so you get dehydration, malnutrition, aspiration, pressure injury, and venous thromboembolism from immobility.
Then there’s the lethal variant: malignant catatonia — hyperthermia, autonomic instability, and rigidity. That picture overlaps with NMS, and it’s a reason to escalate fast.
The workup
When you suspect it:
- Bush-Francis Catatonia Rating Scale to identify and quantify the signs
- Medical and neurologic workup — you are actively ruling in/out encephalitis, metabolic, infectious causes
- Medication review — what could be driving or worsening it
- A lorazepam challenge — both diagnostic and therapeutic. The classic anchor is roughly 1–2 mg, often IV. Improvement after the challenge supports the diagnosis and starts the treatment in the same move.
The board management
First-line: a benzodiazepine — lorazepam. It’s the answer to “what do you give.” For the refractory or malignant case, the answer is ECT — and ECT is the definitive treatment when catatonia doesn’t respond to benzodiazepines or when it’s malignant and the patient is crashing.
Now the part the distractor is built on. Antipsychotic caution: dopamine blockade can worsen catatonia and precipitate NMS. So you hold or minimize antipsychotics until the catatonia is treated. The patient may carry a psychotic diagnosis and still need their antipsychotic deferred — that’s the counterintuitive move the exam is testing.
Don’t confuse it with
- NMS — itself often antipsychotic-induced; rigidity, hyperthermia, autonomic instability. Malignant catatonia overlaps with it, which is the whole reason antipsychotics are dangerous here.
- Severe psychomotor retardation of depression — slowed, but redirectable, and no posturing.
- Delirium — clouded, fluctuating arousal. In catatonia, arousal is preserved even when the patient won’t respond — that’s the discriminator.
- Drug-induced parkinsonism — a separate EPS picture, not the volition-and-responsiveness syndrome.
Why this trips people up
On paper, “mute and staring” reads as severe psychosis, and severe psychosis reads as “antipsychotic.” The exam exploits that pattern-match. The discipline is to recognize the psychomotor syndrome, remember the GABA mechanism, and reach for the benzodiazepine while holding the antipsychotic — the opposite of the reflex.
This is the same skill the look-alike movement-disorder questions test: the obvious answer is the planted wrong one. Build the discrimination, not the list.
On the exam: catatonia → lorazepam first, ECT if refractory or malignant, and hold antipsychotics because dopamine blockade can worsen it and trigger NMS.
Meridian’s board-prep course drills the high-yield inversions — where the obvious answer is the trap — with worked cases and MSE video demos. Explore the board-prep course.